Kimia Farma (Indonesia) Today
| KAEF Stock | IDR 386.00 36.00 8.53% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Kimia Farma is selling for 386.00 as of the 22nd of March 2025. This is a 8.53 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 382.0. Kimia Farma has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. The company has 5.55 B outstanding shares. More on Kimia Farma Persero
Moving together with Kimia Stock
| 0.67 | BBRI | Bank Rakyat Indonesia | PairCorr |
| 0.8 | BMRI | Bank Mandiri Persero | PairCorr |
| 0.77 | GGRM | Gudang Garam Tbk Earnings Call This Week | PairCorr |
| 0.81 | HMSP | Hanjaya Mandala Sampoerna Earnings Call This Week | PairCorr |
Moving against Kimia Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kimia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kimia Farma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kimia Farma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Director | Honesti Basyir |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Kimia Farma Persero (KAEF) is traded on Jakarta Exchange in Indonesia and employs 11,511 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 5.78 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kimia Farma's market, we take the total number of its shares issued and multiply it by Kimia Farma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kimia Farma Persero operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 5.55 B outstanding shares.
Kimia Farma Persero has accumulated about (1.54 B) in cash recording (223.92 B) of negative cash flow from operations. This results in cash-per-share (CPS) ratio of 122.65.
Check Kimia Farma Probability Of Bankruptcy
Ownership AllocationKimia Farma Persero maintains a total of 5.55 Billion outstanding shares. Kimia Farma Persero secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 95.8 % of Kimia Farma Persero outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kimia Ownership Details
Kimia Farma Persero Risk Profiles
Although Kimia Farma's alpha and beta are two of the key measurements used to evaluate Kimia Farma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.8 | |||
| Standard Deviation | 3.2 | |||
| Variance | 10.23 | |||
| Risk Adjusted Performance | (0.15) |
Kimia Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kimia Farma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Kimia Farma Corporate Management
Elected by the shareholders, the Kimia Farma's board of directors comprises two types of representatives: Kimia Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kimia. The board's role is to monitor Kimia Farma's management team and ensure that shareholders' interests are well served. Kimia Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kimia Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Utama | Pres Director | Profile | |
| I Wijaya | Finance Director | Profile | |
| Jasmine Karsono | RD Marketing | Profile | |
| Nurrachman | Independent Commissioner | Profile | |
| CIA CPIA | Head Audit | Profile |
Other Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.